검색
Celularity Inc
CELU관심 목록에 추가
0.635USD
-0.045-6.57%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
18.39M시가총액
손실P/E TTM
자세한 내용은 Celularity Inc 회사
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.
Celularity Inc 정보
종목 코드 CELU
회사 이름Celularity Inc
상장일May 23, 2019
CEOHariri (Robert J)
직원 수123
유형Ordinary Share
회계 연도 종료May 23
주소170 Park Ave
도시FLORHAM PARK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07932
전화19087682170
웹사이트https://celularity.com/
종목 코드 CELU
상장일May 23, 2019
CEOHariri (Robert J)
Celularity Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.86M
+0.07%
Mr. Vincent Levien
Mr. Vincent Levien
Independent Director
Independent Director
157.55K
+18.31%
Dr. Peter H. Diamandis, M.D.
Dr. Peter H. Diamandis, M.D.
Independent Director
Independent Director
--
--
Ms. Diane L. Parks
Ms. Diane L. Parks
Independent Director
Independent Director
--
--
Mr. Stephen A. Brigido
Mr. Stephen A. Brigido
President - Degenerative Disease
President - Degenerative Disease
--
--
Mr. John R. Haines
Mr. John R. Haines
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
--
--
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Carlos Ramirez
Mr. Carlos Ramirez
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Mr. Joseph Dossantos
Mr. Joseph Dossantos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.86M
+0.07%
Mr. Vincent Levien
Mr. Vincent Levien
Independent Director
Independent Director
157.55K
+18.31%
Dr. Peter H. Diamandis, M.D.
Dr. Peter H. Diamandis, M.D.
Independent Director
Independent Director
--
--
Ms. Diane L. Parks
Ms. Diane L. Parks
Independent Director
Independent Director
--
--
Mr. Stephen A. Brigido
Mr. Stephen A. Brigido
President - Degenerative Disease
President - Degenerative Disease
--
--
Mr. John R. Haines
Mr. John R. Haines
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
--
--
자주 묻는 질문
Celularity Inc의 상위 5대 주주는 누구인가요?
Celularity Inc의 상위 5대 주주는 다음과 같습니다: Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Celularity Inc(CELU)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Celularity Inc의 주식을 보유한 기관은 총 64곳이며, 이들이 보유한 주식의 총 가치는 약 3.75M로 전체 발행 주식의 12.95%를 차지합니다. 이는 2025Q4 대비 -258480.00 증가한 수치입니다.